Antiretroviral Therapy in Resource-Limited Settings: Progress and Evolving Challenges
Tremendous progress has been made in rolling out antiretroviral therapy (ART) in resource-limited settings (RLS). By December 2010, 6.6 million adults and children in low- and middle-income countries were under ART, with an increasing number having access to second-line therapy.
Although non-communicable diseases are a growing problem in people with HIV as they live longer on successful ART, little attention is currently being devoted to their prevention and treatment. Recently, compelling efficacy and safety data from randomized clinical trials on antiretrovirals in different populations were released and pre exposure prophylaxis (PrEP) has emerged as a promising new biomedical strategy for preventing HIV infection.
Participants will leave this workshop with a better understanding on use of second-line ART in RLS, including the complex intersections between chronic HIV infection, long-term antiretroviral drug exposure and chronic-degenerative co-morbidities, and the latest scientific evidence on the use of ART as HIV prevention.
Marco Antônio de Ávila Vitória
July 24 14:30 - 18:00, Mini Room 5